BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2410437)

  • 1. Chromatographic analysis of antituberculosis drugs in biological samples.
    Holdiness MR
    J Chromatogr; 1985 May; 340():321-59. PubMed ID: 2410437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification and determination of antitubercular compounds].
    Iwainsky H; Grunert M; Reutgen H; Sehrt I
    Pharmazie; 1970 Sep; 25(9):505-13. PubMed ID: 4922351
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India.
    Ramachandran G; Chandrasekaran V; Hemanth Kumar AK; Dewan P; Swaminathan S; Thomas A
    Trop Med Int Health; 2013 Sep; 18(9):1141-1144. PubMed ID: 23937703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DRUG TREATMENT OF RENAL TUBERCULOSIS].
    TUOVINEN PI; SUTINEN S
    Suom Laakaril; 1964 Aug; 19():1629-38. PubMed ID: 14179990
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
    Levantine A; Almeyda J
    Br J Dermatol; 1972 Jun; 86(6):651-5. PubMed ID: 4114691
    [No Abstract]   [Full Text] [Related]  

  • 6. Side effects of drugs used to treat tuberculosis.
    Newton RW
    Scott Med J; 1975 Mar; 20(2):47-9. PubMed ID: 47648
    [No Abstract]   [Full Text] [Related]  

  • 7. [ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
    ACEVEDO RC; HERRERO JJ; PILHEU J; RODRIGUEZ E
    Sem Med; 1964 Mar; 124():534-43. PubMed ID: 14156391
    [No Abstract]   [Full Text] [Related]  

  • 8. [NEW COMBINATIONS OF ANTITUBERCULAR AGENTS IN THE TREATMENT OF RENAL TUBERCULOSIS].
    SZENDROEI Z; CSERNUS A
    Magy Seb; 1964 Apr; 17():124-7. PubMed ID: 14152677
    [No Abstract]   [Full Text] [Related]  

  • 9. CHEMOTHERAPY OF TUBERCULOSIS.
    HORNE NW
    Biochem Clin; 1964; 4():207-15. PubMed ID: 14268921
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
    SCHWARTZ WS
    Sem Med; 1964 Mar; 124():523-34. PubMed ID: 14156390
    [No Abstract]   [Full Text] [Related]  

  • 11. RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
    CORPE RF; BLALOCK FA; GROSS JH; GOLDHAMMER EJ
    Am Rev Respir Dis; 1964 Dec; 90():957-60. PubMed ID: 14233802
    [No Abstract]   [Full Text] [Related]  

  • 12. SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
    NOVAK M; JANCIK E
    Acta Tuberc Pneumol Scand; 1964; 45():301-19. PubMed ID: 14234473
    [No Abstract]   [Full Text] [Related]  

  • 13. PULMONARY TUBERCULOSIS.
    CHAVES AD
    Mod Treat; 1964 Mar; 1():330-59. PubMed ID: 14159591
    [No Abstract]   [Full Text] [Related]  

  • 14. SOME PROBLEMS IN THE MANAGEMENT OF TUBERCULOSIS.
    MITCHELL JH
    Br J Clin Pract; 1964 Feb; 18():63-8. PubMed ID: 14115576
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE USE OF ANTIBACILLARY DRUGS].
    BERNARD E; PIERON R
    Cah Coll Med Hop Paris; 1964 Apr; 5():241-51. PubMed ID: 14146836
    [No Abstract]   [Full Text] [Related]  

  • 16. [ETHIONAMIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    ZIERSKI M
    G Ital Chemioter; 1963; 10():110-7. PubMed ID: 14074246
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacokinetics of the antituberculosis drugs.
    Holdiness MR
    Clin Pharmacokinet; 1984; 9(6):511-44. PubMed ID: 6391781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ANTIMICROBIAL SCREEN IN PHTHISIOLOGICAL SURGERY].
    SNAJDR V; KRAKORA P; FISER F; CHODOUNSKA V
    Rozhl Chir; 1963 Oct; 42():712-20. PubMed ID: 14119837
    [No Abstract]   [Full Text] [Related]  

  • 19. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
    SCHLESS JM; ALLISON RF; INGLIS RM; WHITE EF; TOPPERMAN S
    Am Rev Respir Dis; 1965 May; 91():728-37. PubMed ID: 14280946
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
    Prahl JB; Lundqvist M; Bahl JM; Johansen IS; Andersen ÅB; Frimodt-Møller N; Cohen AS
    APMIS; 2016 Nov; 124(11):1004-1015. PubMed ID: 27546025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.